|
Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting'
(Fred Hutchinson Cancer Research Center) Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance approach to manage their disease. Ultimately, these markers may lead to the development of a urine test that could complement prostate biopsy for predicting disease aggressiveness and progression.
Urine test shows prostate cancer risk, U-M study finds
(University of Michigan Health System) A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.
Researchers Use Human Vaccine to Cure Prostate Cancer in Mice
Mayo Clinic investigators and collaborators from the United Kingdom cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. This novel cancer treatment approach encourages the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation treatments. Such a treatment model could some day help people to live tumor free with fewer side effects than those experienced from current therapies.
Radiation Right After Prostate Removal is Cost-Effective, But Less Likely to be Recommended by Urologists
Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital.
Radiation Right After Prostate Removal is Cost-Effective, But Less Likely to be Recommended by Urologists
Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital.
Drug Shows Promise in Prostate Cancer Spread to Bone
A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows.
Protein surge 'not cancer sign'
Further concerns have been raised over the reliability of protein testing as an indicator of prostate cancer.
Researchers Identify Molecular Predictor of Metastatic Prostate Cancer
Finding lays the groundwork for gene-based test.
Researchers Identify Molecular Predictor of Metastatic Prostate Cancer
Finding lays the groundwork for gene-based test.
Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients
(University of Texas M. D. Anderson Cancer Center) Practicing stress management techniques before prostate cancer surgery may help activate the body's immune response leading to quicker recovery, as well as aid in lowering mood disturbance, according to a new study by researchers at the University of Texas MD Anderson Cancer Center.
|
